YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis	ANNALS OF PALLIATIVE MEDICINE
2022	Association between arterial stiffness and left ventricular diastolic function: A large population-based cross-sectional study	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology	ANNALS OF NEUROLOGY
2022	Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial	EUROPEAN JOURNAL OF CANCER
2022	Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system	STEM CELL RESEARCH
2022	2LBA Late Breaking - Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)	EUROPEAN JOURNAL OF CANCER
2022	Preclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation	EUROPEAN JOURNAL OF CANCER
2022	Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
2022	First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors	INVESTIGATIONAL NEW DRUGS
2022	Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure	EUROPEAN JOURNAL OF CANCER
2022	Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure	NUTRIENTS
2022	Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Left atrial strain and clinical outcome in patients with significant mitral regurgitation after surgical mitral valve repair	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants	GASTROENTEROLOGY
2022	Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific	HIV MEDICINE
2022	Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma	LIVER INTERNATIONAL
2022	A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer	NATURE COMMUNICATIONS
2022	Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant	SCIENTIFIC REPORTS
2022	First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors	INVESTIGATIONAL NEW DRUGS
2022	Low Dehydroepiandrosterone (DHEA) Level Is Associated with Poor Immunologic Response among People Living with HIV/AIDS	JOURNAL OF CLINICAL MEDICINE